Concepedia

Amber D. P. Doyle

AD

Statistics

Publications

3

Citations

55

H-Index

3

Active since

2021

Affiliations

University of Southampton(Current)

Karyopharm Therapeutics (United States)

Amber D. P. Doyle is an author at University of Southampton.

Publications per year

2021–2023

3

Publications

3

Selinexor Enhances NK Cell Activation Against Malignant B Cells via Downregulation of HLA-E

Jack G. Fisher, Christopher J. Walker, Amber D. P. Doyle et al. · Frontiers in Oncology · 2021 · 21 citations · Full text

XPO1 inhibition sensitises CLL cells to NK cell mediated cytotoxicity and overcomes HLA-E expression

Jack G. Fisher, Amber D. P. Doyle, Lara V. Graham et al. · Leukemia · 2023 · 21 citations · Full text

KIR2DS2 Expression Identifies NK Cells With Enhanced Anticancer Activity

Matthew D. Blunt, Andrés F. Vallejo, Jack G. Fisher et al. · The Journal of Immunology · 2022 · 13 citations · Full text

1–3 of 3